NCKAP5: A Potential Drug Target for Cysteine Metabolism and Related Diseases

Target Name: NCKAP5

NCBI ID: G344148

NCKAP5

NCKAP5: A Potential Drug Target for Cysteine Metabolism and Related Diseases

NCKAP5 (N-Acetyl-L-Cysteine Prolongase 5) is a gene that encodes a protein known as NCKAP5.NCKAP5 is a non-proteinogenic introns gene located on chromosome 12q14.NCKAP5 is a key regulator of cysteine metabolism, a process that involves the conversion of cysteine to another amino acid called cysteine.

NCKAP5 is a 21-kDa protein that is expressed in various tissues and organs, including the brain, heart, kidneys, and liver.NCKAP5 is involved in the catalytic activity of the cysteine convertase enzyme, which is responsible for converting cysteine to cysteine.

NCKAP5 is a potential drug target for several reasons. Firstly,NCKAP5 is involved in the regulation of cysteine metabolism, which is a crucial step in the production of proteins and other molecules.NCKAP5 dysfunction has been linked to a number of diseases, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

Secondly,NCKAP5 is a key regulator of the production of surfactant, which is a substance that helps to reduce surface tension and is found in various tissues and organs, including the airways, blood vessels, and brain.NCKAP5 dysfunction has been linked to the development of surfactant-deficient conditions, such as hypopalustolar syndrome and dry powder syndrome.

Thirdly,NCKAP5 is involved in the regulation of the production of collagen, a protein that is important for the structure and function of many tissues and organs, including blood vessels, bones, and skin.NCKAP5 dysfunction has been linked to the development of collagen-related diseases, including osteoporosis and rheumatoid arthritis.

Finally,NCKAP5 is a potential drug target because it is involved in the regulation of a variety of cellular processes that are important for human health and development.NCKAP5 dysfunction has been linked to the development of a variety of diseases, including cancer, neurodevelopmental disorders, and aging.

In conclusion,NCKAP5 is a gene that encodes a protein that is involved in the regulation of cysteine metabolism, surfactant production, collagen production, and a variety of cellular processes that are important for human health and development.NCKAP5 dysfunction has been linked to the development of a number of diseases, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.Because of its involvement in these processes,NCKAP5 is a potential drug target for the development of new therapies for a variety of diseases.

Protein Name: NCK Associated Protein 5

The "NCKAP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCKAP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets